Search results for "Perte"

showing 10 items of 1643 documents

Improving Knowledge of Arterial Resistant Hypertension: What Is Relevant?

2013

Resistant hypertension, also known as refractory hypertension in the literature, is a relatively common disease that is associated with elevated cardiovascular and renal risk. Clinical trials suggest that its prevalence is around 35% in hypertensive patients with a baseline blood pressure (BP) > 160/100 mmHg. However, data obtained from registries or from the physician’s office suggest that its prevalence is around 12%. The recent National Health and Nutrition Examination Survey suggests a similar prevalence of 12.3% in diagnosed and treated hypertensive patients. An incidence study conducted at Kaiser Permanente Colorado and Kaiser Permanente Northern California followed up more than 200 0…

Malemedicine.medical_specialtyNational Health and Nutrition Examination Surveybusiness.industrymedicine.medical_treatmentDrug ResistanceResistant hypertensionGeneral MedicineClinical trialBlood pressureRefractoryInternal medicineHypertensionEpidemiologymedicineHumansFemaleDiureticbusinessAntihypertensive AgentsMedical literatureRevista Española de Cardiología (English Edition)
researchProduct

Endothelin-1-induced potentiation of adrenergic responses in the rabbit pulmonary artery: role of thromboxane A(2).

2001

Abstract To examine whether low concentrations of endothelin-1 potentiate the vasocontrictor response to adrenergic stimulation, we recorded the isometric response of rings of rabbit pulmonary artery to electrical stimulation and noradrenaline. Endothelin-1 (10 −10 M) potentiated the contractions induced by electrical stimulation and noradrenaline. The endothelin ET B receptor antagonist (2,6-dimethylpiperidinecarbonyl-γ-methyl-Leu- N in -[Methoxycarbonyl]- d -Trp- d -Nle) (BQ-788, 10 −6 M), but not the endothelin ET A receptor antagonist cyclo( d -Asp-Pro- d -Val-Leu- d -TRP) (BQ-123, 10 −6 M), inhibited the potentiating effects of endothelin-1. Pretreatment with the cyclooxygenase inhibit…

Malemedicine.medical_specialtyNifedipineThromboxanemedicine.drug_classAdrenergicPulmonary ArteryThromboxane A2chemistry.chemical_compoundNorepinephrineThromboxane A2PiperidinesInternal medicinemedicineAnimalsVasoconstrictor AgentsAntihypertensive AgentsPharmacologybiologyDose-Response Relationship DrugEndothelin-1Receptors EndothelinReceptor antagonistCalcium Channel BlockersEndothelin 1Receptor Endothelin BElectric StimulationEndocrinologychemistryVasoconstrictionbiology.proteinCyclooxygenaseThromboxane-A synthaseRabbitsEndothelin receptorOligopeptidesEuropean journal of pharmacology
researchProduct

Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension.

1999

Hypertension is a side effect of systemically administered glucocorticoids, but the underlying molecular mechanism remains poorly understood. Ingestion of dexamethasone by rats telemetrically instrumented increased blood pressure progressively over 7 days. Plasma concentrations of Na + and K + and urinary Na + and K + excretion remained constant, excluding a mineralocorticoid-mediated mechanism. Plasma NO 2 − /NO 3 − (the oxidation products of NO) decreased to 40%, and the expression of endothelial NO synthase (NOS III) was found down-regulated in the aorta and several other tissues of glucocorticoid-treated rats. The vasodilator response of resistance arterioles was tested by intravital m…

Malemedicine.medical_specialtyNitric Oxide Synthase Type IIIDown-RegulationVasodilationBiologyEndothelial NOSRats Inbred WKYUmbilical veinDexamethasonechemistry.chemical_compoundInternal medicinemedicineAnimalsRNA MessengerPromoter Regions GeneticAortaCells CulturedNitritesDNA PrimersMultidisciplinaryNitratesBase SequenceAntiglucocorticoidNitric Oxide Synthase Type IIIBiological SciencesRatsNitric oxide synthaseVasodilationEndocrinologychemistryHypertensionbiology.proteinEndothelium VascularNitric Oxide SynthaseGlucocorticoidIntravital microscopymedicine.drugTranscription FactorsProceedings of the National Academy of Sciences of the United States of America
researchProduct

Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: Relationship to clinical status

2013

Abstract Aims The present study investigates the expression and clinical relevance of the constitutive NO synthases in heart and peripheral blood mononuclear cells (PBMCs) obtained from heart failure patients. Main methods mRNA and protein levels (qRT-PCR and immunoblot) of eNOS and nNOS were determined in: i) Left ventricle (LV, n = 4) and PBMCs (n = 10) from healthy donors; ii) LV, right ventricle (RV) and PBMCs of heart failure (HF) patients (n = 32); and iii) biopsies and PBMCs of the HF patients after cardiac transplant (n = 15). Key findings Expression of constitutive NOS isoforms in heart exhibits wide variability in HF patients, but this variability was not related to aetiology, dis…

Malemedicine.medical_specialtyNitric Oxide Synthase Type IIIHeart Ventriclesmedicine.medical_treatmentCardiac indexNitric Oxide Synthase Type IPeripheral blood mononuclear cellGeneral Biochemistry Genetics and Molecular BiologyPredictive Value of TestsEnosInternal medicinemedicineHumansClinical significanceGeneral Pharmacology Toxicology and PharmaceuticsHeart FailureHeart transplantationbiologybusiness.industryGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationPulmonary hypertensionmedicine.anatomical_structureVentricleHeart failureLeukocytes MononuclearCardiologyHeart TransplantationFemalebusinessLife Sciences
researchProduct

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.

2019

Purpose: To evaluate the additive intraocular pressure–lowering effect of twice-daily brinzolamide 1%/brimonidine 0.2% fixed-dose combination (BBFC) as an adjunct to a prostaglandin analog (PGA) in patients with open-angle glaucoma or ocular hypertension insufficiently controlled with PGA monotherapy. Methods: In this Phase 4, double-masked trial, patients aged ⩾18 years, with a mean intraocular pressure of ⩾19 and <32 mm Hg in at least one eye were randomized (1:1) to receive BBFC + PGA ( n = 96) or vehicle + PGA ( n = 92) for 6 weeks. The primary endpoint was the mean change in diurnal intraocular pressure from baseline (averaged over 09:00 and 11:00 h) at Week 6. Results: The mean diu…

Malemedicine.medical_specialtyOpen angle glaucomagenetic structuresFixed-dose combinationBrinzolamideThiazinesOcular hypertensionopen-angle glaucoma03 medical and health sciencesTonometry Ocular0302 clinical medicineTravoprostDouble-Blind Methodintraocular pressure reductionOphthalmologyOriginal Research ArticlesmedicineAdrenergic alpha-2 Receptor AgonistsHumansCarbonic Anhydrase InhibitorsAntihypertensive AgentsIntraocular PressureAgedAged 80 and overSulfonamidesbusiness.industryprostaglandin analogsBrimonidineBrinzolamide/brimonidine fixed-dose combinationGeneral MedicineMiddle Agedmedicine.diseaseAdjuncteye diseasesOphthalmologyDrug CombinationsProstaglandin analogBrimonidine Tartrate030221 ophthalmology & optometryLatanoprostocular hypertensionFemalesense organsbusiness030217 neurology & neurosurgeryGlaucoma Open-Anglemedicine.drugEuropean journal of ophthalmology
researchProduct

Pacemaker-Based Cardiac Neuromodulation Therapy in Patients With Hypertension: A Pilot Study.

2021

Background In prior unblinded studies, cardiac neuromodulation therapy (CNT) employing a sequence of variably timed short and longer atrioventricular intervals yielded sustained reductions of systolic blood pressure (SBP) in patients with hypertension. The effects of CNT on SBP were investigated in this double‐blind randomized pilot study. Methods and Results Eligible patients had daytime ambulatory SBP (aSBP) ≥130 mm Hg and office SBP ≥140 mm Hg despite taking ≥1 antihypertensive medication, and an indication for a dual‐chamber pacemaker. Patients underwent Moderato device implantation, which was programmed as a standard pacemaker during a 1‐month run‐in phase. Patients whose daytime aSBP…

Malemedicine.medical_specialtyPacemaker ArtificialTime Factorshypertensionatrioventricular interval ; hypertension ; left ventricular function ; pacemakerBlood PressurePilot ProjectsArrhythmiasVentricular Function LeftDouble-Blind MethodHeart RateInternal medicineMedicineHumansIn patientProspective StudiesSequence (medicine)AgedOriginal ResearchAged 80 and overbusiness.industryCardiac Pacing ArtificialEditorialsHeartNeuromodulation (medicine)EuropeTreatment OutcomeEditorialCardiologyFemaleCardiology and Cardiovascular Medicinebusinesshigh blood pressureJournal of the American Heart Association
researchProduct

Influence of Concurrent Obesity and Low Birth Weight on Blood Pressure Phenotype in Youth

2009

The aim of this study was to assess the impact of obesity and low birth weight on both office and ambulatory blood pressure (BP) values, as well as on aortic-derived parameters in youths. A total of 422 white youths, from 10 to 18 years of age, were included. Subjects were divided into 4 groups according to the presence (234; 55%) or the absence (188; 45%) of obesity and according to low (114; 27%) or normal (308; 73%, birth weight. Spacelabs 90207 was used to measure ambulatory BP during a 24-hour period. SphygmoCor radial/aortic transform software was used to estimate aortic pressure waveform. Office, 24-hour, daytime, and nighttime systolic BP values were significantly higher in those s…

Malemedicine.medical_specialtyPediatricsAmbulatory blood pressureAdolescentBirth weightObesidadSeverity of Illness IndexBody Mass IndexPeso de nacimiento; Obesidad; Adolescencia; Presión sanguíneaCohort StudiesAge DistributionReference ValuesInternal medicineHeart rateInternal MedicinemedicineHumansObesitySex DistributionChildProbabilitybusiness.industryIncidenceInfant NewbornBlood Pressure Monitoring AmbulatoryInfant Low Birth WeightPrognosis:CIENCIAS MÉDICAS [UNESCO]medicine.diseasePresión sanguíneaObesityLow birth weightBlood pressureHypertensionMultivariate AnalysisAdolescenciaUNESCO::CIENCIAS MÉDICASAmbulatoryLinear ModelsCardiologyPeso de nacimientoFemalemedicine.symptombusinessBody mass indexHypertension
researchProduct

Clinical Inertia in Poorly Controlled Elderly Hypertensive Patients: A Cross-Sectional Study in Spanish Physicians to Ascertain Reasons for Not Inten…

2013

Clinical inertia, the failure of physicians to initiate or intensify therapy when indicated, is a major problem in the management of hypertension and may be more prevalent in elderly patients. Overcoming clinical inertia requires understanding its causes and evaluating certain factors, particularly those related to physicians.The objective of our study was to determine the rate of clinical inertia and the physician-reported reasons for it.An observational, cross-sectional, multi-center study was carried out in a primary care setting. We included 512 physicians, with a consecutive sampling of 1,499 hypertensive patients with clinical inertia.Clinical inertia was defined when physicians did n…

Malemedicine.medical_specialtyPediatricsMedicinaCross-sectional studyTreatment outcomeAlternative medicineMEDLINEPharmacotherapyPhysiciansmedicineHumansCorPharmacology (medical)Hypertension diagnosisIntensive care medicineAntihypertensive AgentsAgedPhysician-Patient Relationsbusiness.industryGeneral MedicineMiddle AgedCross-Sectional StudiesTreatment OutcomeMulticenter studySpainHypertensionFemaleClinical CompetenceClinical competenceCardiology and Cardiovascular MedicinebusinessAmerican Journal of Cardiovascular Drugs
researchProduct

Hospitalization Within the First Year After Stroke

2014

Background and Purpose— This population-based study aimed to identify unplanned hospitalization within the first year after stroke to determine factors associated with it and consequences on survival. Methods— All first-ever acute strokes occurring in Dijon, France, from 2009 to 2011, were prospectively collected from a population-based registry. Demographics and clinical data, including stroke severity measured by the National Institutes of Health Stroke Scale and disability after stroke, were recorded. For each patient, the first unplanned hospitalization that occurred within 1 year after stroke was retrieved by linking data with the national French Hospital Discharge Database. Predictor…

Malemedicine.medical_specialtyPediatricsStroke registryStatistics as TopicPopulationStroke severityLogistic regressionAtrial FibrillationEpidemiologymedicineHumansRegistrieseducationStrokeAgedAged 80 and overAdvanced and Specialized Nursingeducation.field_of_studybusiness.industryStroke scaleHospital discharge databaseMiddle Agedmedicine.diseaseHospitalizationStrokeHypertensionFemaleFranceNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessStroke
researchProduct

Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pres…

2019

OBJECTIVE: Hyperuricemia has been associated with high blood pressure (BP) values, diabetes mellitus, metabolic syndrome and chronic kidney disease (CKD). In the present study, we assessed the gender-related relationships between serum uric acid (SUA) and cardionephrometabolic variables in central and east European hypertensive patients. METHODS: A total of 3206 treated hypertensive patients with available SUA levels from the BP-CARE study was analyzed. Correlations among SUA, BP values, BP control, diabetes mellitus, metabolic syndrome and CKD were performed according to gender. RESULTS: Twenty-five percent of the whole population showed hyperuricemia (28% in women and 23% in men). These p…

Malemedicine.medical_specialtyPhysiologyCross-sectional studyBlood PressureComorbidityHyperuricemia030204 cardiovascular system & hematologyurologic and male genital diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSex FactorsRisk FactorsDiabetes mellitusInternal medicineInternal MedicinemedicineDiabetes MellitusPrevalenceHumans030212 general & internal medicineHyperuricemiaEurope EasternRenal Insufficiency ChronicAgedMetabolic Syndromebusiness.industrynutritional and metabolic diseasesMiddle AgedCardiovascular riskKidney damagemedicine.diseaseComorbidityUric AcidBlood pressureCross-Sectional StudieschemistryHypertensionUric acidFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessKidney diseaseJournal of hypertension
researchProduct